FdaApplication
ANDA 212591
Identifiers
- fda_app_no: ANDA212591
Properties
| Property | Value |
|---|---|
| applicant_name | NIVAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2021-10-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLYCOPYRROLATE | GLYCOPYRROLATE | 0.2MG/ML | INJECTABLE;INJECTION |
1 product